Skip to content
Johnson & Johnson announced Wednesday it is buying the world leader in breakthrough heart, lung, and kidney support technologies, Abiomed, “for an upfront payment […]
Johnson & Johnson strengthens MedTech business, acquires Abiomed Read More »
The WTO IP waiver for COVID-19 vaccines was never about vaccine distribution—it was a political calculation, according to Hans Sauer, Deputy General Counsel for
WTO IP waiver was always political: BIO’s patent lawyer breaks it down Read More »
“Short” is the next big thing for corn. Bayer AG’s Crop Science division is developing corn hybrids that are more efficient in several ways—and
Bayer’s short-stature corn can protect crop yields Read More »
Using synthetic biology to make consumer products more sustainable has proven to be a winning formula for Amyris, a BIO member company that announced expansion in
Making sustainable products with synbio is a winning formula for Amyris Read More »
A paper from the Innovation and Value Initiative (IVI) and Sick Cells, a national sickle cell advocacy organization, demonstrates how traditional approaches used to
Value assessments can exacerbate health inequity, report finds Read More »
Pfizer announced yesterday that results from the Phase 3 clinical trial of its maternal vaccine candidate against the highly contagious Respiratory Syncytial Virus (RSV)
Pfizer says clinical trial shows their candidate RSV maternal vaccine protects the baby Read More »
U.S. farm productivity continues to grow, but the pace is slowing due to adverse climate conditions, indicating a need for advances in biotech and
Tech solutions needed to boost farm productivity, USDA economists say Read More »
Scientific and commercial acceptance of the use of psychedelics as treatments for PTSD, anxiety, and other mental disorders has created an exciting new field
Industry, regulators opening their minds to psychedelics as treatments Read More »
Rachel King was enjoying her retirement. When the COVID-19 pandemic hit, King found herself with a chance to refocus and ask herself what was
Meet Rachel King, BIO’s new interim CEO and a champion of the biotech industry Read More »
As the weather is getting colder with the winter months approaching, the very scary possibility of a “twindemic” of COVID-19 and influenza we’ve discussed
RSV, COVID, and flu ‘tripledemic’ risk runs high Read More »
